Patents Assigned to L2 Diagnostics, LLC
  • ErbB peptide pharmaceutical and vaccine compositions and therapeutic uses thereof for cancer
    Patent number: 11890335
    Abstract: Disclosed herein are peptide-adjuvant pharmaceutical compositions and vaccine compositions that trigger long lasting natural anti-tumor antibodies. Such compositions may be used alone, or in combination with anti-cancer agents, chemotherapeutic agents, anti-PD therapy, chemotherapy, radiation therapy, and surgery, in the prevention and treatment of cancer.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: February 6, 2024
    Assignees: L2 Diagnostics, LLC, Yale University
    Inventors: Mark Mamula, Raymond A. Koski